Spyre Therapeutics

SYRE

Market cap $2.57B

33.06 USD

+0.09

0.27%

At close Updated Dec 17, 4:00 PM EST

Pre-market

After hours

33.40

+0.34

1.03%

1 day

0.27%

5 days

-4.92%

1 month

35.71%

3 months

119.67%

6 months

117.79%

Year to date

38.62%

1 year

30.88%

5 years

-85.12%

10 years

-86.46%

About: Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Employees: 95

Healthcare Biotechnology